• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Yae-eun Suh, Nina Raulf, +7 authors Mahvash Tavassoli
  • Medicine
  • International journal of cancer
  • 2015 (First Publication: 1 September 2015)
  • Radiotherapy is a major treatment modality for head and neck squamous cell carcinoma (HNSCC). Up to 50% of patients with locally advanced disease relapse after radical treatment and there isContinue Reading
  • Nina Raulf, Radien Hm El-Attar, +6 authors Mahvash Tavassoli
  • Medicine
  • British Journal of Cancer
  • 2014 (First Publication: 14 October 2014)
  • Background:Current treatment strategies for head and neck cancer are associated with significant morbidity and up to 50% of patients relapse, highlighting the need for more specific and effectiveContinue Reading
  • Hersi Mohamed Hersi, Nina Raulf, Joop Gaken, Najeem'deen Folarin, Mahvash Tavassoli
  • Biology, Medicine
  • Molecular oncology
  • 2018 (First Publication: 25 October 2018)
  • Head and neck squamous cell carcinomas (HNSCC) are associated with poor morbidity and mortality. Current treatment strategies are highly toxic and do not benefit over 50% of patients. There isContinue Reading
  • Jessica Bullenkamp, Nina Raulf, +5 authors Mahvash Tavassoli
  • Biology, Medicine
  • Cell Death and Disease
  • 2014 (First Publication: 1 October 2014)
  • Human papillomavirus (HPV) is causative for a new and increasing form of head and neck squamous cell carcinomas (HNSCCs). Although localised HPV-positive cancers have a favourable response toContinue Reading
  • E Alsahafi, Nina Raulf, Hm Hersi, Katheryn Begg, J Naglik, Mahvash Tavassoli
  • Medicine
  • 2018 (First Publication: 1 July 2018)
  • Introduction Squamous cell carcinoma of the head and neck (HNSCC) is a significant cause of morbidity and mortality, with over 6 00 000 new cases diagnosed annually. Development of targeted agents toContinue Reading